Epstein-Barr Virus-Associated Gastric Cancer in a Patient with Dermatomyositis

Internal Medicine

Volumn 40, Issue 2, 2001, Pages 96-99

  Yamashita, Kentaro ^a,b   Hosokawa, Masayo ^a   Hirohashi, Sae ^a   Arimura, Yoshiaki ^a   Endo, Takao ^a   Denno, Ryuichi ^a   Ikeda, Tatsuru ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Epstein Barr virus encoded RNA (EBER); In situ hybridization; Paraneoplastic syndrome

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; CANCER STEM CELL; CASE REPORT; DERMATOMYOSITIS; EPSTEIN BARR VIRUS; GASTRECTOMY; HUMAN; ISOLATION AND PURIFICATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROME; STOMACH TUMOR; VIROLOGY; VIRUS INFECTION;

ADENOCARCINOMA; BIOLOGICAL MARKERS; DERMATOMYOSITIS; EPSTEIN-BARR VIRUS INFECTIONS; GASTRECTOMY; HERPESVIRUS 4, HUMAN; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 0035260045     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.96     Document Type: Article

References (20)

1. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 326: 363-367, 1992.
2. Callen JP. Dermatomyositis and malignancy. Clin Dermatol 11: 61-65, 1993.
3. Bonnetblanc JM, Bernard P, Fayol J. Dermatomyositis and malignancy. Dermatologica 180: 212-216, 1990.
4. Kurzrock R, Cohen PR. Cutaneous paraneoplastic syndromes in solid tumors. Am J Med 99: 662-671, 1995.
5. Kaneko K, Kikuchi R, Arai Y, Hidano M. Dermatomyositis and malignancy. Hifu Rinsyo 27: 499-505, 1985 (in Japanese).
6. Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 3: 377-380, 1990.
7. Min KW, Holmquist S, Peiper SC, O'Leary TJ. Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas) of the stomach; report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. Am J Clin Pathol 96: 219-227, 1991.
8. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration; lymphoepithelioma-like carcinoma. Am J Pathol 139: 469-474, 1991.
9. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57: 4749-4756, 1997.
10. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of the Epstein-Barr virus. Cancer Res 41: 4253-4261, 1981.
11. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320: 502-506, 1989.
12. Ley vraz S, Henle W, Chahinian AP, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 312: 1296-1299, 1985.
13. Begin LR, Eskandari J, Joncas J, Panasci L. Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung. J Surg Oncol 36: 280-283, 1987.
14. Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol 143: 1250-1254, 1993.
15. Ott G, Kirchner T, Muller-Hermelink HK. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology 25: 323-329, 1994.
16. Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer 77: 1998-2004, 1996.
17. Wang HH, Wu MS, Shun CT, Wang HP, Lin CC, Lin JT. Lymphoepithelioma-like carcinoma of the stomach: a subset of gastric carcinoma with distinct clinicopathological features and high prevalence of Epstein-Barr virus infection. Hepatogastroenterology 46: 1214-1219, 1999.
18. Bowles NE, Dubowitz V, Sewry CA, Archard LC. Dermatomyositis, polymyositis and Coxsackie B-virus infection. Lancet 1 (8540): 1004-1007, 1987.
19. Mathews MB. Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304: 177-179, 1983.
20. Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25: 638-643, 1994.